After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, IRWD falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Ironwood Pharmaceuticals Inc is $233.00M. A total of 1.52 million shares were traded on the day, compared to an average of 3.25M shares.
In the most recent transaction, MCCOURT Thomas A sold 139,064 shares of IRWD for 1.76 per share on Feb 10 ’25. After the transaction, the Chief Executive Officer now owns 1,160,634 company shares. In a previous transaction on Feb 10 ’25, Silver Ronald sold 12,048 shares at 1.76 per share. IRWD shares that Principal Accounting Officer owns now total 279,655.
Among the insiders who sold shares, Shetzline Michael disposed of 41,269 shares on Feb 10 ’25 at a per-share price of $1.76. This resulted in the SVP, CMO, Head-Res&Drug holding 554,007 shares of IRWD after the transaction. In another insider transaction, John Minardo sold 38,938 shares at $1.76 per share on Feb 10 ’25. Company shares held by the Chief Legal Officer now total 408,132.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, IRWD has a high of $8.56 and a low of $1.32.
As of this writing, IRWD has an earnings estimate of -$0.01 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of $0.03 per share and a lower estimate of -$0.05.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. IRWD’s latest balance sheet shows that the firm has $620.13M in Cash & Short Term Investments as of fiscal 2021. There were $475.80M in debt and $161.70M in liabilities at the time. Its Book Value Per Share was -$1.88, while its Total Shareholder’s Equity was $605.91M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IRWD is Buy with a score of 4.67.
